Neoadjuvant and adjuvant systemic therapy for breast cancer give equivalent survival, study finds

The timing of systemic therapy--chemotherapy or endocrine therapy--for breast cancer does not appear to affect survival or disease progression. However, women who receive systemic therapy and radiation therapy without surgery may be more likely to experience a recurrence of their cancer compared with women treated with chemotherapy later, according to a new study in the February 2 issue of the Journal of the National Cancer Institute.

Neoadjuvant--also called preoperative or primary--systemic therapy for breast cancer may result in local tumor regression or even in a complete tumor response and may lead to a more limited extent of surgery--from radical mastectomy to some type of breast-conserving surgery--without risking patient survival. For these reasons, interest in the use of neoadjuvant therapy has been increasing.

To investigate how the timing of systemic therapy affects breast cancer outcomes, John P.A. Ioannidis, M.D., of the University of Ioannina School of Medicine in Greece, and colleagues performed a meta-analysis of nine randomized trials that had included nearly 4,000 breast cancer patients. The patients had been treated with systemic therapy either before or after surgery and/or radiation therapy.

There was no difference between neoadjuvant and adjuvant systemic therapy in terms of death, disease progression, or distant disease recurrence. However, neoadjuvant therapy was associated with a 22% increased risk of loco-regional disease recurrence compared with adjuvant therapy. This risk was higher (53%) when radiation therapy was used without surgery.

"[T]his meta-analysis demonstrates the equivalence of neoadjuvant and adjuvant treatments for breast cancer in terms of survival, disease progression, and distant recurrence and shows that an increased risk of loco-regional disease recurrence is associated with neoadjuvant treatment, especially when primary systemic treatment is not accompanied by any surgical interve

Contact: Sarah L. Zielinski
Journal of the National Cancer Institute

Page: 1 2

Related medicine news :

1. MRI better than current standard in assessing neoadjuvant chemotherapy for breast cancer
2. Updated adjuvant data presented at SABCS show 30 percent reduction in recurrence
3. Different methods of adjuvant chemotherapy for colorectal cancer have similar outcomes
4. Study supports tailoring adjuvant therapy for early-stage breast cancer
5. Nordic collaboration gives new insights into adjuvant chemotherapy
6. Tumor-targeted immune cells cure prostate cancer in mice without causing systemic immune suppression
7. A blood test may reveal systemic factors that relate to periodontal disease, especially in men
8. Important information to consider about non-systemic cholesterol lowering agents
9. Study shows patch therapy may be as effective as oral medications
10. Novel therapy tested in mice could chase away cat allergies
11. Drug therapy may be comparable to invasive cardiac procedures for elderly patients with heart attack

Post Your Comments:
(Date:5/26/2015)... Javon Bea President and CEO Mercy ... her quality improvement and organizational development expertise in ... leadership and direction for the financial, budget, marketing and ... Care and Mercy Durable Medical Equipment. , Denise has ... the last 20 in home care administration. In addition ...
(Date:5/26/2015)... The professionals from Marietta Vet Clinic ... helping local rescue pets with a parking lot cookout ... Kimmerling DDS, Suzanna Aguilera DMD and Garrick McGrath DMD ... 100% of proceeds from the extravaganza. , Tents, grills ... to help save unwanted, local animals. Doctors and ...
(Date:5/25/2015)... La. (PRWEB) May 26, 2015 Author Vincent ... number of people today are overweight, and many of them ... health. He also knows that most people don’t realize the ... environmental hazards and man-made toxins that exist. There ... don’t realize exactly how serious tobacco is.” , In “ ...
(Date:5/25/2015)... 2015 World Patent Marketing, a vertically ... Preventer, a home patent that aims to protect both ... "House fires cost the United States a total of ... Creative Director of World Patent Marketing . "More ... that have no alarmed protection. With the use of ...
(Date:5/25/2015)... 2015 A recent report for Mass ... have died as a direct result of an opiate overdose ... 33% rise in overdose deaths attributed to prescription opiate medications, ... doesn’t care about geography. This issue doesn’t care about race. ... about class.” As the state of Mass. reels from the ...
Breaking Medicine News(10 mins):Health News:"Rescue Animal Cookout" Announced at Verde Pointe Professional Park on June 25, 2015 2Health News:New Book Reveals ‘A Doctor’s Prescription for Longevity and Survival’ 2Health News:New Book Reveals ‘A Doctor’s Prescription for Longevity and Survival’ 3Health News:Home Maintenance Causes House Fires? World Patent Marketing Introduces the Best Home Patent to Prevent Fire Accidents 2Health News:Home Maintenance Causes House Fires? World Patent Marketing Introduces the Best Home Patent to Prevent Fire Accidents 3Health News:Opioid Deaths Increase by 33 Percent Since 2012 in Mass. 2
(Date:5/26/2015)... UAE, May 26, 2015 For ... & Quality of Life Throughout Europe, the ...    Astellas Pharma EMEA is celebrating its ... founding through the historic merger of Japanese pharmaceutical companies ... years, committed to turning science into value for patients ...
(Date:5/22/2015)... , May 22 2015 /CNW/ - The Taskforce representing ... very appreciative of all the hard work that the Minister ... past six months. This program recognizes the needs of the ... at least $75,000 a year, tax free, with annual adjustments ... be eligible for annual payments of $100,000 based on the ...
(Date:5/22/2015)... 2015 /CNW/ - More than fifty years ago, Thalidomide was ... in expectant mothers. Tragically, Thalidomide caused serious and permanent physical ... Support has been provided to survivors over the years ... Canada in 1991 and settlements from drug companies. ... obligation to provide support, we have a clear moral obligation ...
Breaking Medicine Technology:Astellas Pharma EMEA Celebrates Its 10th Anniversary 2Astellas Pharma EMEA Celebrates Its 10th Anniversary 3Astellas Pharma EMEA Celebrates Its 10th Anniversary 4Statement from Minister Ambrose on Thalidomide 2Statement from Minister Ambrose on Thalidomide 3
Cached News: